OPEN Health Acquires ARK
September 23, 2021 |
OPEN Health has today announced the acquisition of London-based agency ARK to further strengthen omnichannel capabilities
Joining forces to further strengthen our omnichannel capabilities
September 23, 2021, London, UK – OPEN Health has today announced the acquisition of London-based agency ARK. ARK has a unique approach to delivering data-driven, digital-first creative campaigns. Integrating the ARK business with the OPEN Health Group further strengthens our global creative, digital-first resources, and our ability to offer our global clients measurable omnichannel campaigns.
In terms of scale, the acquisition means OPEN Health will now consist of approximately 875 people in 16 locations across 6 different countries including the USA, UK, The Netherlands, Germany, India and China.
Dominic Marchant, Founder and Chief Creative Officer of ARK, said, “Over the past three years, we have proudly grown both the core ARK business and the ARK Comms sister agency to ensure clients receive data-driven campaigns where digital is truly integrated. In joining OPEN Health, we are significantly expanding our geographical reach and will be able to work with the expert in-house digital team to deliver a wider range of omnichannel creative services to our clients. We very much look forward to working with the OPEN Health management and Amulet teams to contribute to the long-term growth of OPEN Health.”
Rob Barker, Chief Executive Officer at OPEN Health comments, “We are delighted to welcome ARK into the OPEN Health family – this is a strategic acquisition to enhance our already excellent creative and digital capabilities, further supporting our unique range of offerings and opportunities for innovation to support industry change and growth.”
The merger enhances and supports OPEN Health’s positioning – deep, broad, and united:
- Deep in that the acquisition will further enhance the deep levels of creative, digital and data-driven expertise and the global understanding our teams have, to ensure we can deliver innovative, market-leading solutions for our clients.
- Broad in terms of the ability to offer clients a truly comprehensive breadth of expertise across many Centers of Excellence and deliver world-class communications across a wide range of media.
- United as one flexible organization, with a highly skilled and diverse team working together across the globe to harness the power of the collective to solve complex challenges and deliver truly innovative and best-in-class solutions to our clients. Strong interpersonal and cultural fit are the underpinnings of the business integration, with shared values around collaboration and intellectual curiosity.
OPEN Health is a portfolio company of Amulet Capital Partners, LP, a US-based private equity firm focused exclusively on the healthcare sector.
Contact
Sandy Royden, COO OPEN Health
Email: sandyroyden@openhealthgroup.com
Tel: +44 7837 945243
Candice Subero, Global Marketing Lead
Email: candicesubero@openhealthgroup.com
Tel: +1 240-483-4323
About OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
We are united as one flexible organization, harnessing the power of the collective to solve complex challenges. Being built from cohesive partnerships across a range of specialist sectors (including the Peloton and Pharmerit integrations back in December 2018 and November 2019, respectively), gives us the ability to approach opportunities from fresh perspectives, creating solutions and innovations for market access and medical communications that are informed by the experience and knowledge of the many.
Our global team of experts — many with PhD and PharmD degrees — work strategically alongside our client partners in Medical Affairs, Health Economics and Outcomes Research (HEOR), Market Access, and Commercial teams across a wide range of therapy areas.
OPEN Health – Established as many. United as one.
For more information on OPEN Health, please visit www.openhealthgroup.com
About ARK
ARK is the first data-driven, digital-first creative agency in healthcare. ARK takes the traditional creative approach to advertising, medical communications and PR and adds data to help sharpen its effectiveness. From brand strategy through to implementation, ARK builds omnichannel campaigns. ARK Comms was founded a year after ARK launched and specialises in developing human-centered health and medical communications, again with a data-driven, digital-first mindset.
For further information on ARK, please visit www.ARK.agency
For further information on ARK Comms, please visit www.ARKcomms.agency
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
OPEN Health’s response to the FDA’s guidance on long term follow up post gene therapy
Written by Gavin Jones, OPEN Health
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy
OPEN Health becomes sponsor of MedComms Networking
New for 2020, OPEN Health is pleased to announce its sponsorship of MedComms Networking
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.
Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?
A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....
Spotlight interview: 15 minutes on insights and market research in pharma
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma
OPEN Health reflections on the World Orphan Drug Congress in Barcelona
Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications...